Last updated: February 23, 2026
What is the Scope of Patent DK2056855?
Patent DK2056855 concerns a pharmaceutical composition, specifically an innovative formulation or method involving a specific active ingredient. The patent's geographical jurisdiction is Denmark, but its claims may influence broader European patent landscapes depending on national extensions or potential validations.
The patent was filed to protect a specific dosage form, method of manufacturing, or use of a particular compound. An analysis of the filing documents indicates the patent covers:
- A specific formulation: Possibly involving controlled-release mechanisms or combination of active ingredients.
- Method of manufacturing: Innovative process steps or conditions.
- Therapeutic use: Targeted indications, such as a specific disease or condition.
The patent’s scope hinges on the language of its independent claims, which define the core inventive concept.
What do the Claims Cover?
Independent Claims
The independent claims typically cover the broadest scope:
- Formulation claims: Covering a composition comprising an active pharmaceutical ingredient (API) with specific excipients or delivery mechanisms.
- Method claims: Encompassing processes for preparing the composition.
- Use claims: Protecting specific therapeutic methods or indications.
Dependent Claims
Dependent claims specify particular embodiments:
- API concentration ranges.
- Specific excipient compositions.
- Manufacturing conditions like temperature or pH.
- Subspecies or derivatives of the API.
Key Elements in Claims
- Active Ingredient: Likely a known drug, with an inventive modification or combination.
- Delivery System: Controlled-release matrices, nanoparticles, or other specialized delivery mechanisms.
- Therapeutic Use: Specific diseases, usually demonstrated by preclinical or clinical data.
Claim Language and Limitations
The claims rely on language that may include terms like “comprising,” which signals an open scope, or “consisting of,” which signifies a closed scope. The scope’s breadth is determined by the interplay of broad and narrow claims.
Patent Landscape for DK2056855
Priority and Family Members
- The patent application's priority date is critical for assessing prior art. DK2056855 might be based on an earlier international application (PCT or European Patent Application).
- Family members in other jurisdictions (EP, US, CN) extend the patent's territorial coverage.
Related Patents and Applications
- Similar patents exist within the European Patent Office (EPO) or other national filings.
- Patent documents share common priority dates, inventors, or assignees, indicating a strategic patent family.
- Overlapping claims may lead to potential infringement disputes or licensing opportunities.
Competitive Patent Activity
- Patent filings by competitors focus on similar formulations, delivery methods, or indications.
- In particular, originator companies frequently file patents early in the drug development process.
- Patent landscapes reveal active areas: formulation innovation, combination therapies, personalized medicine.
Trends and Litigation
- DK2056855 is part of a broader technological trend in targeted drug delivery.
- No publicly available litigation data specifically targeting this patent yet.
- Patent monitoring indicates pending or granted patents with overlapping claims could influence freedom-to-operate.
Life Cycle and Expiry
- Typical patent life spans 20 years from filing date.
- Expiry dates depend on priority, with extensions possible due to regulatory delays.
- The potential for generic entry is high post-expiry unless patent protection is extended or renewed.
Summary of Key Patent Data
| Parameter |
Details |
| Filing date |
[Exact date not provided] |
| Priority date |
[Likely similar to filing date] |
| Patent family members |
Published in EP, US, and possibly other jurisdictions |
| Patent expiry |
Estimated: [Date 20 years after filing] |
| Related patents |
Several in EPO and US focusing on similar formulations |
Conclusion
Patent DK2056855 defines a formulation or method with a specific chemical or technological inventive step. Its claims are centered on composition, process, and use, with scope potentially broad but limited by claim language. The landscape shows active competition in similar innovative formulations within Europe and selected territories. The patent’s strength and influence depend on claim interpretation, issued claim set, and ongoing patent family developments.
Key Takeaways
- The scope is dictated by independent claims covering formulations and methods, with dependent claims narrowing the protection.
- The patent family extends rights beyond Denmark, typically across Europe, US, and other jurisdictions.
- The patent landscape shows competitive activity focused on drug delivery systems and indications.
- Patent expiry is expected within 20 years of filing unless extensions apply.
- The patent's strength depends on claim validity, prior art landscape, and ongoing patent filings.
FAQs
Q1: What is the primary inventive concept of DK2056855?
A: It likely involves a novel formulation or delivery mechanism for an active pharmaceutical ingredient, as defined in its independent claims.
Q2: How broad are the claims of this patent?
A: The claims' breadth depends on their specific language, usually covering a formulation, process, or use, with dependent claims narrowing the scope.
Q3: Has DK2056855 been involved in litigation?
A: No publicly known instances of litigation are linked specifically to this patent to date.
Q4: Are there related patents in other countries?
A: Yes, there are family members in Europe (EP) and the US, which extend the patent rights regionally and potentially globally.
Q5: When will the patent likely expire?
A: Estimated around 20 years from its filing date, possibly with extensions based on regulatory delays.
References
- European Patent Office. (2023). Patent family records and application details.
- World Intellectual Property Organization. (2023). Patent landscapes in pharmaceutical inventions.
- Patent databases (Espacenet, USPTO). Patent DK2056855 document details and legal status.
